The minutes of the meeting of the CMDh subgroup dedicated to the publication of the list of safety concerns and prospectuses have been published with proposals for the current failure to update the list of safety concerns (T3).

As of 01 Apr 2024, the EMA MLM service has extended its coverage also to MEDLINE (T1, T2, T3).

The EMA has published a new update (v. 136) of the ‘List of European Union reference dates and frequency of submission of periodic safety update reports’ (T2,T3).

A new version (1.3) of the ‘Guidance on the electronic submission of information on investigational medicinal products in the XEVMPD) has been published. (T1, T2, T3).

A new version of the document ‘EVVet3 Production-Releases notes’ T1, T2, T3 has been published.

New ‘UPD Releases notes (15 March 2024)’ (T1, T2, T3) have been published.

A new version of the document ‘New organization First User QPPV/RP or Change of EU QPPV/RP’ (13 March 2024) has been published (T1, T2, T3).

A new version of the EV Registration Manual (Rev. 14) has been published (T1, T2, T3).

A new version (13 Mar 2024) of the ‘Eudravigilance registration documents’ (T1, T2, T3) has been published.

New version (29 Feb 2024) of the ‘EV user declaration for qualified person for pharmacovigilance/responsible perrson of EV’, ‘Connecting to the Agency ESTRI Gateway (29 Feb 2024) and ‘EV Human Sponsor Registration form'(29 Feb 2024) (T1, T2, T3) have been published.

A new version ( 29 FEB 2024) of the ‘Eudravigilance support guide’ (T1, T2, T3) has been published.

A new version (1.7) of the ‘Eudravigilance-EVWEB User Manual’ (T1, T2, T3) has been published.
